CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ESALY

Lecanemab

Phase 3
Eisai (ESALY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
ESALYPhase 2

Lecanemab Phase 2 Est. Readout

Lecanemab
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Preclinical Alzheimer's Disease

View Full Landscape
Drug Information

Target Indication

Preclinical Alzheimer's Disease

Clinical Trial

NCT04468659

Last updated: 12/23/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.